Individuals Coming Off Anti-Obesity Jabs Gain Back Weight Four Times Faster Than People Using Diet and Exercise

Fresh analysis suggests that patients who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt traditional lifestyle plans.

Findings released in a leading health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month once they quit.

"People purchasing such treatments should be aware of the danger of fast weight regain when the treatment concludes," stated expert Dr. Susan Jebb.

This pace of recovery implies a return to original mass in about a year and a half.

Comparing Treatments

The research, which looked at 37 of studies involving thousands of patients, compared the results of GLP-1 agonists with other pills.

The team point out that people who shed pounds through diet and exercise generally see a slower creep back—perhaps 0.1 kg a month—post-intervention.

The Reason for the Rapid Rebound

Experts suggest the mode of action of the jabs accounts for the heightened rebound.

GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making excessive eating a significant risk."

An Ongoing Issue?

Health authorities recommend the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.

Many experts argue that, considering the significant potential of weight regain, the treatment is often long-term.

This opinion is echoed by drug manufacturers, who state that the findings "highlight the long-term character of obesity," comparing it to managing diseases like high blood pressure.

User Accounts

People who have come off the jabs describe a sudden return of appetite.

"I experienced a switch flipping and you're instantly starving," said a patient.

The struggle is worsened if individuals have not established lasting lifestyle or habit modifications during therapy.

Widespread Adoption

Survey data indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.

• Use is higher among females than men.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the medications through private prescriptions rather than the NHS.

Ultimately, clinicians emphasize that while these medications are potent tools for weight loss, they are not a permanent cure and lasting health benefits likely depends on integrated lifestyle management.